Valuation: Psychemedics Corporation

Market Cap 9.79M 8.78M 8.03M 7.33M 13.8M 920M 14.24M 96.74M 38.57M 491M 36.75M 35.96M 1.55B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.56M 7.82M 7.14M 13.45M 897M 13.87M 94.26M 37.59M 479M 35.81M 35.04M 1.51B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
6 months+21.46%
Current year+55.62%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+20.87%+5.96% 15.26M
-2.46%+3.54%+4.60%+114.43% 106B
+3.10%-7.17%+6.75%+19.36% 104B
-14.59%-28.75%+55.40%+626.88% 52.43B
+10.49%0.00%-2.19%+85.70% 32.79B
+0.90%-0.43%+46.22%+74.37% 29.5B
+0.35%+1.07%+43.40%+90.90% 28.03B
-1.09%+4.72%+35.81%+415.90% 22.8B
+1.12%-2.57%-19.05%-14.02% 20.12B
-0.26%-1.91%-7.00%+28.55% 16.86B
Average +1.23%-1.74%+18.48%+144.80% 41.26B
Weighted average by Cap. -0.58%-2.80%+16.77%+155.71%

Financials

2023 2024
Net sales 22.1M 19.82M 18.11M 16.53M 31.15M 2.08B 32.13M 218M 87.06M 1.11B 82.94M 81.17M 3.5B 19.68M 17.66M 16.14M 14.73M 27.75M 1.85B 28.63M 194M 77.55M 987M 73.89M 72.3M 3.12B
Net income -4.15M -3.73M -3.4M -3.11M -5.86M -390M -6.04M -41.04M -16.37M -208M -15.59M -15.26M -658M -1.86M -1.67M -1.53M -1.39M -2.62M -175M -2.71M -18.39M -7.33M -93.34M -6.99M -6.84M -295M
Net Debt 334K 300K 274K 250K 471K 31.4M 486K 3.3M 1.32M 16.75M 1.25M 1.23M 52.89M -251K -225K -206K -188K -354K -23.59M -365K -2.48M -989K -12.59M -942K -922K -39.74M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock